14 completed, 2 recruiting, 1 terminated, 1 unknown. 18 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 18 | Completed 14, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 2 | 7 | Completed 5, Recruiting 1, Terminated 1 |
Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MDMA Assisted Therapy for BN MDMA-AT, MDMA-AT-BN, Standard Treatment (ST) - Bulimia Nervosa | Phase 1 | Recruiting | Icahn School of Medicine at Mount Sinai | 40 | 2026-05-22 | 2026-06-22 |
| A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity Digital - Binge Eating Disorder Associated With Obesity, Binge Eating Disorder | Phase 1 / Phase 2 | Recruiting | Drexel University | 30 | 2025-02-01 | 2025-02-17 |
| A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP) Sodium Glycerophosphate Injection, Sodium Phosphates Injection - Parenteral Nutrition | Phase 1 | Completed | Baxter Healthcare Corporation | 42 | 2025-01-27 | 2025-06-29 |
| A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E Numeta G16%E, Sodium Glycerophosphate Injection - Parenteral Nutrition | Phase 1 | Completed | Baxter Healthcare Corporation | 16 | 2025-01-27 | 2025-06-29 |
| Project CORE: Disseminating Eating Disorders Treatment Family Based Treatment, Enhanced Cognitive Behavioral Therapy - Anorexia Nervosa/Bulimia, Anorexia Nervosa Restricting Type | Phase 1 | Unknown | The Miriam Hospital | 20 | 2019-01-01 | 2021-02-23 |
| LIPIDS-P Trial Phase I/II Trial Smoflipid - Sepsis, Severe, Septic Shock | Phase 1 / Phase 2 | Completed | University of Florida | 59 | 2018-08-17 | 2025-08-11 |
| SMOFlipid to Lessen the Severity of Neonatal Cholestasis SMOFlipid - Cholestasis, Jaundice, Obstructive | Phase 1 / Phase 2 | Terminated | University of Florida | 2 | 2016-05-01 | 2017-04-17 |
| FDA Approved Medication to Reduce Binge Eating and/or Purging Phentermine/Topiramate-First, Placebo - Binge Eating Disorder, Bulimia Nervosa | Phase 1 | Completed | Stanford University | 22 | 2015-10-30 | 2018-05-14 |
| Smartphone Technology and CBT-GSH in Binge Eaters CBT-GSH, Noom Monitor - Binge Eating Disorder, Bulimia Nervosa | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 66 | 2013-02-01 | 2016-05-03 |
| Repetitive Transcranial Magnetic Stimulation of the DMPFC for Anorexia and Bulimia: an Open-Label Case Series Repetitive Transcranial Magnetic Stimulation - Bulimia Nervosa, Anorexia Nervosa | Phase 1 | Completed | University Health Network, Toronto | 60 | 2011-12-11 | 2020-06-01 |
| Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training Nutritional Counseling, Mindfulness Intervention - Stress, Obesity | Phase 1 | Completed | Yale University | 112 | 2010-09-01 | 2015-07-30 |
| Binge Eating and Chromium Study Sugar Pill, chromium picolinate - Binge Eating Disorder | Phase 1 / Phase 2 | Completed | University of North Carolina, Chapel Hill | 26 | 2008-07-01 | 2012-04-03 |
| Cholestasis Prevention: Efficacy of IV Fish Oil Omegaven, Intralipid - Cholestasis, Parenteral Nutrition | Phase 1 | Completed | Boston Children's Hospital | 19 | 2007-07-01 | 2020-12-03 |
| Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain Interpersonal Psychotherapy - Overweight Adolescents, Overweight | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 147 | 2005-12-05 | 2017-10-06 |
| Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents Cognitive Behavioral Therapy - Bulimia Nervosa | Phase 1 / Phase 2 | Completed | Kaiser Permanente | 26 | 2005-09-01 | 2010-02-15 |
| Internet Weight Control for Bingeing Adolescents Internet-based intervention designed to reduce binge eating and improve healthy weight regulation - Obesity, Eating Disorders | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 120 | 2005-02-01 | 2010-01-18 |
| The Psychological Treatment of Overweight Binge Eaters Minority Supplement Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT) - Binge Eating Disorder, Cognitive Therapy/Methods | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 162 | 1997-04-01 | 2010-09-28 |
| Psychological Treatment of Overweight Binge Eaters Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT) - Binge Eating Disorder, Cognitive Therapy/Methods | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 162 | 1994-04-01 | 2010-09-23 |
Bulimia (12) · Binge-Eating Disorder (6) · Bulimia Nervosa (6) · Feeding and Eating Disorders (6) · Obesity (5) · Anorexia Nervosa (2) · Cholestasis (2) · Mental Disorders (2) · Anorexia (1) · Enterocolitis, Necrotizing (1) · Jaundice, Obstructive (1) · Overweight (1) · Sepsis (1) · Shock, Septic (1)
Pathological Conditions, Signs and Symptoms (18) · Signs and Symptoms (18) · Signs and Symptoms, Digestive (18) · Mental Disorders (10) · Feeding and Eating Disorders (6) · Body Weight (5) · Nutrition Disorders (5) · Nutritional and Metabolic Diseases (5) · Overnutrition (5) · Overweight (4) · Pathologic Processes (3) · Bile Duct Diseases (2) · Biliary Tract Diseases (2) · Digestive System Diseases (2)
Cognitive Behavioral Therapy (3) · SMOFlipid (2) · alpha-glycerophosphoric acid (2) · Interpersonal Psychotherapy (1) · Nutrition Assessment (1) · Parenteral Nutrition (1) · Parenteral Nutrition, Total (1) · Phentermine (1) · Qsymia (1) · Sugars (1) · Transcranial Magnetic Stimulation (1) · fish oil triglycerides (1) · picolinic acid (1) · soybean oil, phospholipid emulsion (1)
Baxter Healthcare Corporation (2) · Icahn School of Medicine at Mount Sinai (2) · University of Florida (2) · Washington University School of Medicine (2) · Boston Children's Hospital (1) · Drexel University (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Kaiser Permanente (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Stanford University (1) · The Miriam Hospital (1) · University Health Network, Toronto (1) · University of North Carolina, Chapel Hill (1) · Yale University (1)
United States (16)
Denise E Wilfley, Ph.D. (2) · Erika Ryan, DCN, MS, RD, CDN, CNSC (2) · Tom Hildebrandt, PsyD (2) · Andrea B. Goldschmidt, Ph.D. (1) · Blake Woodside, MD (1) · C. Barr Taylor, M.D. (1) · Christina Tortolani, Ph.D. (1) · Debra L Safer, MD (1) · Faheem W Guirgis, MD (1) · Jack A Yanovski, M.D. (1) · Jonathan Downar, MD (1) · Josef Neu, MD (1) · Kimberly A Brownley, PhD (1) · Lynn L DeBar, PhD MPH (1) · Mark Puder, MD, PhD (1)
PMID 12150647, PMID 18310192, PMID 22282429, PMID 23751236, PMID 23770843, PMID 26210388, PMID 28714097, PMID 28960384, PMID 29038069, PMID 31537565, PMID 31721257, PMID 33392541, PMID 33865456, PMID 38271099, PMID 38488429, PMID 39716214
R41MH096435 (1), R41MH134704 (1)